Literature DB >> 17363747

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.

Subhashini Yaturu1, Barbara Bryant, Sushil K Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17363747     DOI： 10.2337/dc06-2606

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  51 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

2.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

Review 3.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 4.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

Review 5.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

6.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

Review 7.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 8.  Diabetes and fractures: an overshadowed association.

Authors:  Natasha B Khazai; George R Beck; Guillermo E Umpierrez
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

9.  Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy.

Authors:  Allison C Ross; Corrilynn O Hileman; Todd T Brown; Neal Fedarko; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  HIV Clin Trials       Date:  2012 Jul-Aug

10.  Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone.

Authors:  Unni Syversen; Astrid K Stunes; Björn I Gustafsson; Karl J Obrant; Lars Nordsletten; Rolf Berge; Liv Thommesen; Janne E Reseland
Journal:  BMC Endocr Disord       Date:  2009-03-30       Impact factor: 2.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.